Результаты поиска - Xianglei Yan

  • Отображение 1 - 5 результаты of 5
Отмена результатов
  1. 1
    Bcl‐2/Bcl‐xl inhibitor APG‐1252‐M1 is a promising therapeutic strategy for gastric carcinoma

    Bcl‐2/Bcl‐xl inhibitor APG‐1252‐M1 is a promising therapeutic strategy for gastric carcinoma по Hanjie Yi, Miao‐Zhen Qiu, Luping Yuan, Qiuyun Luo, Wentao Pan, Suna Zhou, Lin Zhang, Xianglei Yan, Dajun Yang

    Опубликовано 2020
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Biochemical and hematological reference intervals in rhesus and cynomolgus macaques and implications for vaccine and drug development

    Biochemical and hematological reference intervals in rhesus and cynomolgus macaques and implications for vaccine and drug development по Xianglei Yan, Rodrigo Arcoverde Cerveira, Sebastian Ols, Klara Lenart, Fredrika Hellgren, Marcos C. Miranda, Olivia Engstrand, Annika Reinhardt, Bengt I. Eriksson, Karin Loré

    Опубликовано 2025
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma

    A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma по Hanjie Yi, Xianglei Yan, Qiuyun Luo, Luping Yuan, Baoxia Li, Wentao Pan, Lin Zhang, Haibo Chen, Jing Wang, Yu Zhang, Yifan Zhai, Miao‐Zhen Qiu, Da-Jun Yang

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell Lymphoma

    A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell Lymphoma по Qiuyun Luo, Wentao Pan, Suna Zhou, Guangfeng Wang, Hanjie Yi, Lin Zhang, Xianglei Yan, Luping Yuan, Zhenyi Liu, Jing Wang, Haibo Chen, Miao‐Zhen Qiu, Dajun Yang, Jian Sun

    Опубликовано 2020
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses

    A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses по Klara Lenart, Fredrika Hellgren, Sebastian Ols, Xianglei Yan, Alberto Cagigi, Rodrigo Arcoverde Cerveira, Inga Patrycja Winge, Jakub Hanczak, Stefan O. Mueller, Edith Jasny, Kim Schwendt, Susanne Rauch, Benjamin Petsch, Karin Loré

    Опубликовано 2022
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: